New diagnostic techniques for diagnosing facture-related infections.
Culture
Fracture-related infection
Host factors
Mircobiological diagnostics
Sonication
Journal
Injury
ISSN: 1879-0267
Titre abrégé: Injury
Pays: Netherlands
ID NLM: 0226040
Informations de publication
Date de publication:
Nov 2024
Nov 2024
Historique:
received:
29
02
2024
revised:
04
09
2024
accepted:
15
09
2024
medline:
1
11
2024
pubmed:
1
11
2024
entrez:
31
10
2024
Statut:
ppublish
Résumé
The diagnosis of fracture-related infections (FRI) is challenging and requires interdisciplinary efforts. Many diagnostic approaches are based on the algorithms established for prosthetic joint infections (PJI). Data specific to FRI are limited. Microbiological diagnostics include tissue culture, sonication, and molecular methods. Novel metagenomic analyses are increasingly being used in clinical diagnostic practice. In addition to bacterial detection, the study of host tissue factors has the potential to transform the diagnostics of FRI by facilitating the assesment of clinical significance in clinical samples. The integration of host tissue analysis into microbiology reports has great potential to improve the diagnosis of FRI. This mini-review describes the potential improvement of diagnostic techniques by integrating new approaches into the diagnostic algorithm of fracture-related infections.
Identifiants
pubmed: 39482031
pii: S0020-1383(24)00627-2
doi: 10.1016/j.injury.2024.111898
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
111898Informations de copyright
Copyright © 2024. Published by Elsevier Ltd.
Déclaration de conflit d'intérêts
Declaration of competing interest Ada Hoffmann(1): AH received a travel grant from Gilead. Jörgen Hoffmann(2): No conflict of interest. Tamara Ruegamer(1): TR received lecture honoraria from Hikma. Norma Jung(3): NJ has received lecture fees from AbbVie, Bayer, Infectopharm, and Medacta and travel grants from Gilead and Pfizer and fees for advisory board from MSD. Ronald Man Yeung Wong(4): No conflict of interest. Volker Alt(5): No conflict of interest. Peer Eysel(2): No conflict of interest. Jonathan Jantsch(1,6): No conflict of interest.